These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36875053)

  • 21. Synergistic Therapy of a Naturally Inspired Glycopolymer-Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability.
    Duan Z; Luo Q; Dai X; Li X; Gu L; Zhu H; Tian X; Zhang H; Gong Q; Gu Z; Luo K
    Adv Mater; 2021 Nov; 33(45):e2104594. PubMed ID: 34554623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes.
    Tao W; Zhao D; Li G; Li L; Li S; Ye H; Tian C; Lu Y; Li S; Sun Y; He Z; Sun J
    Acta Pharm Sin B; 2022 Mar; 12(3):1487-1499. PubMed ID: 35530142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy.
    Huang G; Chen H; Dong Y; Luo X; Yu H; Moore Z; Bey EA; Boothman DA; Gao J
    Theranostics; 2013; 3(2):116-26. PubMed ID: 23423156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy.
    Wu Y; Li F; Zhang X; Li Z; Zhang Q; Wang W; Pan D; Zheng X; Gu Z; Zhang H; Gong Q; Luo K
    Carbohydr Polym; 2021 Mar; 255():117490. PubMed ID: 33436250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy.
    Zuo W; Chen D; Fan Z; Chen L; Zhu Z; Zhu Q; Zhu X
    Acta Biomater; 2020 Jul; 111():327-340. PubMed ID: 32434075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells.
    Park MT; Song MJ; Lee H; Oh ET; Choi BH; Jeong SY; Choi EK; Park HJ
    PLoS One; 2011; 6(10):e25976. PubMed ID: 21998736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
    Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J
    J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer.
    Huang J; Zhuang C; Chen J; Chen X; Li X; Zhang T; Wang B; Feng Q; Zheng X; Gong M; Gong Q; Xiao K; Luo K; Li W
    Adv Mater; 2022 Jul; 34(27):e2201516. PubMed ID: 35481881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific nitric oxide generator to amplify peroxynitrite based on highly penetrable nanoparticles for metastasis inhibition and enhanced cancer therapy.
    Shi M; Zhang J; Wang Y; Peng C; Hu H; Qiao M; Zhao X; Chen D
    Biomaterials; 2022 Apr; 283():121448. PubMed ID: 35245730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lapatinib-loaded acidity-triggered charge switchable polycarbonate-doxorubicin conjugate micelles for synergistic breast cancer chemotherapy.
    Guo Z; Liang E; Sui J; Ma M; Yang L; Wang J; Hu J; Sun Y; Fan Y
    Acta Biomater; 2020 Dec; 118():182-195. PubMed ID: 33045399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapy.
    Shu M; Tang J; Chen L; Zeng Q; Li C; Xiao S; Jiang Z; Liu J
    Biomaterials; 2021 Jan; 268():120574. PubMed ID: 33271451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel albumin-binding photodynamic agent EB-Ppa for targeted fluorescent imaging guided tumour photodynamic therapy.
    Liu H; Yu C; Lyu M; Lyu S; Hu L; Xiao E; Xu P
    RSC Adv; 2023 Jan; 13(6):3534-3540. PubMed ID: 36756591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release.
    Wang S; Yu G; Wang Z; Jacobson O; Lin LS; Yang W; Deng H; He Z; Liu Y; Chen ZY; Chen X
    Angew Chem Int Ed Engl; 2019 Oct; 58(41):14758-14763. PubMed ID: 31429173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
    Mao C; Li F; Zhao Y; Debinski W; Ming X
    Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine.
    Cilurzo F; Cristiano MC; Da Pian M; Cianflone E; Quintieri L; Paolino D; Pasut G
    Anticancer Agents Med Chem; 2019; 19(12):1513-1522. PubMed ID: 31241440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer.
    Liu R; An Y; Jia W; Wang Y; Wu Y; Zhen Y; Cao J; Gao H
    J Control Release; 2020 May; 321():589-601. PubMed ID: 32114091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.
    Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W
    Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.